Analysts expect Walgreens Boots Alliance to report an earnings per share (EPS) of $0.34. Investors in Walgreens Boots Alliance are eagerly awaiting the company's announcement, hoping for news of ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is an American multinational company providing retail, pharmacy, and healthcare services. The company has approximately 12,500 locations across the US, ...

Discover the pros and cons of investing in PINE, offering a 12% AFFO yield but facing tenant risks and expiring loans.

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) will be announcing earnings results this Thursday before market open.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $111.7, a high estimate of $135.00, and a low estimate of $85.00. Witnessing a positive shift, the current ...

Meanwhile, Walgreens' stock price is around $11.20 per share, which means there's around $0.25 per share in possible gains here for investors trying to arbitrage the takeover.

Shares of pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) jumped 7.4% in the morning session after the company agreed to be acquired by Sycamore Partners for $10 billion. The acquisition ...

Walgreens investors may be feeling jaded with these developments. Not only has the stock been an awful buy over the past five ...

For decades, investors have been able to rely on growing dividend payments from pharmacy retailer Walgreens Boots Alliance (WBA-0.57%).But earlier this year, the company announced that it would be ...

Not only has the stock been an awful buy over the past five years (it has declined by more than 75% during that time frame), ... Walgreens investors may be feeling jaded with these developments.

Walgreens Will Make Big Changes in 2025 Walgreens is on track to make significant changes in 2025, and one possibility is to sell itself. The news from late 2024 includes rumors of a debt-financed ...

Walgreens was the worst stock in the S&P 500 last year. An analyst writes that it's still 'premature to say that Walgreens is on a stable path to growth' despite upbeat earnings.